Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Braz. j. med. biol. res ; 43(6): 565-571, June 2010. ilus, tab
Article in English | LILACS | ID: lil-548267

ABSTRACT

Genetic polymorphisms of adrenergic receptors (ARs) have been associated with the development, progression, and prognosis of patients with heart failure (HF), with few data for the Brazilian population. We evaluated the role of the β2-AR Thr164Ile polymorphism at codon 164 on prognosis in a prospective study on 315 adult Brazilian HF patients, predominantly middle-aged Caucasian men in functional class I-II, with severe left ventricular systolic dysfunction. Genomic DNA was extracted from peripheral blood and β2-AR164 genotypes were detected by PCR followed by restriction fragment length analysis. During a median follow-up of 3 years, 95 deaths occurred and 57 (60 percent) were HF-related. Unexpectedly, Ile164 carriers (N = 12) had no HF-related events (log-rank P value = 0.13). Analysis using genotype combination with β1-AR polymorphisms at codons 49 and 389 identified patients with favorable genotypes (Thr164Ile of β2-AR, Gly49Gly of β1-AR and/or Gly389Gly of β1-AR), who had lower HF-related mortality (P = 0.01). In a Cox proportional hazard model adjusted for other clinical characteristics, having any of the favorable genotypes remained as independent predictor of all-cause (hazard ratio (HR): 0.41, 95 percentCI: 0.17-0.95) and HF-related mortality (HR: 0.12, 95 percentCI: 0.02-0.90). These data show that the β2-AR Thr164Ile polymorphism had an impact on prognosis in a Brazilian cohort of HF patients. When combined with common β1-AR polymorphisms, a group of patients with a combination of favorable genotypes could be identified.


Subject(s)
Female , Humans , Male , Middle Aged , Heart Failure/genetics , Polymorphism, Genetic/genetics , /genetics , Cohort Studies , Genetic Predisposition to Disease , Genotype , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Prognosis , Prospective Studies , Severity of Illness Index
2.
Braz. j. med. biol. res ; 41(3): 250-257, Mar. 2008. ilus, tab
Article in English | LILACS | ID: lil-476579

ABSTRACT

Our objective was to evaluate the effectiveness of a long-acting formulation of methylphenidate (MPH-SODAS) on attention-deficit/hyperactivity disorder (ADHD) symptoms in an outpatient sample of adolescents with ADHD and substance use disorders (SUD). Secondary goals were to evaluate the tolerability and impact on drug use of MPH-SODAS. This was a 6-week, single-blind, placebo-controlled crossover study assessing efficacy of escalated doses of MPH-SODAS on ADHD symptoms in 16 adolescents with ADHD/SUD. Participants were randomly allocated to either group A (weeks 1-3 on MPH-SODAS, weeks 4-6 on placebo) or group B (reverse order). The primary outcome measures were the Swanson, Nolan and Pelham Scale, version IV (SNAP-IV) and the Clinical Global Impression Scale (CGI). We also evaluated the adverse effects of MPH-SODAS using the Barkley Side Effect Rating Scale and subject reports of drug use during the study. The sample consisted of marijuana (N = 16; 100 percent) and cocaine users (N = 7; 43.8 percent). Subjects had a significantly greater reduction in SNAP-IV and CGI scores (P < 0.001 for all analyses) during MPH-SODAS treatment compared to placebo. No significant effects for period or sequence were found in analyses with the SNAP-IV and CGI scales. There was no significant effect on drug use. MPH-SODAS was well tolerated but was associated with more severe appetite reduction than placebo (P < 0.001). MPH-SODAS was more effective than placebo in reducing ADHD symptoms in a non-abstinent outpatient sample of adolescents with comorbid SUD. Randomized clinical trials, with larger samples and SUD intervention, are recommended.


Subject(s)
Adolescent , Adult , Humans , Male , Attention Deficit Disorder with Hyperactivity/drug therapy , Central Nervous System Stimulants/therapeutic use , Methylphenidate/therapeutic use , Substance-Related Disorders/drug therapy , Attention Deficit Disorder with Hyperactivity/complications , Cross-Over Studies , Central Nervous System Stimulants/adverse effects , Methylphenidate/adverse effects , Single-Blind Method , Substance-Related Disorders/complications , Treatment Outcome
3.
Braz. j. med. biol. res ; 39(10): 1281-1290, Oct. 2006. ilus, tab, graf
Article in English | LILACS | ID: lil-437816

ABSTRACT

The main function of the cardiac adrenergic system is to regulate cardiac work both in physiologic and pathologic states. A better understanding of this system has permitted the elucidation of its role in the development and progression of heart failure. Regardless of the initial insult, depressed cardiac output results in sympathetic activation. Adrenergic receptors provide a limiting step to this activation and their sustained recruitment in chronic heart failure has proven to be deleterious to the failing heart. This concept has been confirmed by examining the effect of ß-blockers on the progression of heart failure. Studies of adrenergic receptor polymorphisms have recently focused on their impact on the adrenergic system regarding its adaptive mechanisms, susceptibilities and pharmacological responses. In this article, we review the function of the adrenergic system and its maladaptive responses in heart failure. Next, we discuss major adrenergic receptor polymorphisms and their consequences for heart failure risk, progression and prognosis. Finally, we discuss possible therapeutic implications resulting from the understanding of polymorphisms and the identification of individual genetic characteristics.


Subject(s)
Humans , Cardiac Output, Low/genetics , Cardiac Output, Low/physiopathology , Polymorphism, Genetic/genetics , Receptors, Adrenergic, alpha/genetics , Receptors, Adrenergic, beta/genetics , Disease Progression , Prognosis , Receptors, Adrenergic, alpha/physiology , Receptors, Adrenergic, beta/physiology
4.
Braz. j. med. biol. res ; 38(9): 1409-1416, Sept. 2005. tab
Article in English | LILACS | ID: lil-408372

ABSTRACT

End-stage renal disease (ESRD) patients frequently develop structural cardiac abnormalities, particularly left ventricular hypertrophy (LVH). The mechanisms involved in these processes are not completely understood. In the present study, we evaluated a possible association between parathyroid hormone (PTH) levels and left ventricular mass (LVM) in patients with ESRD. Stable uremic patients on intermittent hemodialysis treatment were evaluated by standard two-dimensional echocardiography and their sera were analyzed for intact PTH. Forty-one patients (mean age 45 years, range 18 to 61 years), 61 percent males, who had been on hemodialysis for 3 to 186 months, were evaluated. Patients were stratified into 3 groups according to serum PTH: low levels (<100 pg/ml; group I = 10 patients), intermediate levels (100 to 280 pg/ml; group II = 10 patients) and high levels (>280 pg/ml; group III = 21 patients). A positive statistically significant association between LVM index and PTH was identified (r = 0.34; P = 0.03, Pearson's correlation coefficient) in the sample as a whole. In subgroup analyses, we did not observe significant associations in the low and intermediate PTH groups; nevertheless, PTH and LVM index were correlated in patients with high PTH levels (r = 0.62; P = 0.003). LVM index was also inversely associated with hemoglobin (r = -0.34; P = 0.03). In multivariate analysis, after adjustment for age, hemoglobin, body mass index, and blood pressure, the only independent predictor of LVM index was PTH level. Therefore, PTH is an independent predictor of LVH in patients undergoing chronic hemodialysis. Secondary hyperparathyroidism may contribute to the elevated cardiovascular morbidity associated with LVH in ESRD.


Subject(s)
Adolescent , Adult , Female , Humans , Male , Middle Aged , Hyperparathyroidism, Secondary/complications , Hypertrophy, Left Ventricular/etiology , Kidney Failure, Chronic/complications , Parathyroid Hormone/blood , Renal Dialysis , Echocardiography , Hypertrophy, Left Ventricular/blood , Hypertrophy, Left Ventricular , Kidney Failure, Chronic/therapy , Multivariate Analysis , Risk Factors
5.
Braz. j. med. biol. res ; 37(6): 863-867, Jun. 2004. tab
Article in English | LILACS | ID: lil-359900

ABSTRACT

The diagnosis of avoidant disorder was deleted from the Diagnostic and Statistical Manual of Mental disorders - fourth edition (DSM-IV) based on a `committee decision' suggesting that avoidant disorder is part of the social phobia spectrum. The objective of the present study was to examine the nature of this clinical association in a referred sample of Brazilian children and adolescents. We assessed a referred sample of 375 youths using semi-structured diagnostic interview methodology. Demographic (age at admission to the study and sex) and clinical (level of impairment, age at onset of symptoms and pattern of comorbidity) data were assessed in subsamples of children with avoidant disorder (N = 7), social phobia (N = 26), and comorbidity between both disorders (N = 24). Although a significant difference in the male/female ratio was detected among groups (P = 0.03), none of the other clinical variables differed significantly among subjects that presented each condition separately or in combination. Most of the children with avoidant disorder fulfilled criteria for social phobia. Thus, our findings support the validity of the conceptualization of avoidant disorder as part of the social phobia spectrum in a clinical sample.


Subject(s)
Humans , Male , Female , Child , Adolescent , Personality Disorders , Phobic Disorders , Anxiety Disorders , Brazil , Comorbidity , Diagnostic and Statistical Manual of Mental Disorders , Interview, Psychological , Psychiatric Status Rating Scales
6.
Rev. Col. Bras. Cir ; 11(3): 65-7, 1984.
Article in Portuguese | LILACS | ID: lil-23371

ABSTRACT

Os autores fazem um estudo comparativo entre os resultados dos exames citopatologicos de material obtido por puncao aspirativa, em 105 casos de nodulos isolados da tireoide, com os resultados dos exames anatomopatologicos por inclusao em parafina


Subject(s)
Humans , Biopsy, Needle , Thyroid Diseases
7.
Rev. AMRIGS ; 27(4): 484-7, 1983.
Article in Portuguese | LILACS | ID: lil-18274

ABSTRACT

Trata-se de um caso raro, num menino de 10 anos que apresentava crises de dor no hipocondrio direito e epigastrico, em consequencia de colecistite aguda. No entanto os exames habitualmente realizados nesta situacao, revelaram-se normais. A suspeita diagnostica de anomalia de forma de vesicula so foi possivel na ocasiao pelo estudo laparoscopico, com o diagnostico definitivo atraves de cirurgia e estudo radiologico transoperatorio. Estes confirmaram a presenca de vesicula com septacao transoperatorio. Estes confirmaram a presenca de vesicula com septacao transversal, com formacao consequente de dois compartimentos isolados e com colecistite aguda no distal. Este tipo de anomalia de forma e extremamente raro. Mais raro ainda e a instalacao concomitante de colecistite aguda. Na literatura existe um caso descrito de colecistite aguda, mas em vesicula dupla


Subject(s)
Child , Humans , Male , Cholecystitis , Congenital Abnormalities , Gallbladder
8.
Rev. AMRIGS ; 26(1): 27-33, 1982.
Article in Portuguese | LILACS | ID: lil-8623

ABSTRACT

Os autores apresentam sua experiencia com tres casos de cistos isolados de figado, nao parasitado. Abordam o quadro clinico, os meios de diagnostico e a conduta cirurgica. Chamam a atencao para o diagnostico diferencial como o cisto hidatico, especialmente, quando o doente provem de zona endemica


Subject(s)
Adult , Middle Aged , Humans , Female , Cysts , Liver Diseases , Angiography , Radionuclide Imaging , Ultrasonics
9.
J. pneumol ; 8(2): 93-6, 1982.
Article in Portuguese | LILACS | ID: lil-8891

ABSTRACT

Um homem de 29 anos de idade, previamente higido, apresentou severa pneumonia com insufuciencia respiratoria aguda. Estudos sorologicos indicaram infeccao por Mycoplasma pneumoniae. O tratamento com doxiciclina foi bem sucedido


Subject(s)
Adult , Humans , Male , Mycoplasma pneumoniae , Pneumonia, Mycoplasma
SELECTION OF CITATIONS
SEARCH DETAIL